https://www.pcori.org/about/pcoris-advisory-panels/advisory-panel-clinical-effectiveness-and-decision-science-ceds/biographies-advisory-panel-clinical-effectiveness-and-decision-science-ceds

Tanawin presents research on lung function trajectories
At the BWH Lung Research Day, Dr. Nopsopon shared the results of our research on the lung function trajectories in patients with asthma treated with mepolizumab, dupilumab, or omalizumab. There were a lot of interesting questions and insights on this work.